The majority of them regarded the anti-DFS70 antibodies as less prevalent in SLE patients than in healthy individuals, except for one research performed by Japanese scholars, indicating that there was no significant difference in the prevalence of anti-DFS70 antibodies between SLE patients (22.1%) and healthy individuals (16.4%) (11). This evidence concerns the gene PSIP1 and systemic lupus erythematosus.